GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTK Healthcare Ltd (NSE:TTKHLTCARE) » Definitions » EV-to-Revenue

TTK Healthcare (NSE:TTKHLTCARE) EV-to-Revenue : 1.63 (As of May. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is TTK Healthcare EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, TTK Healthcare's enterprise value is ₹12,171 Mil. TTK Healthcare's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹7,470 Mil. Therefore, TTK Healthcare's EV-to-Revenue for today is 1.63.

The historical rank and industry rank for TTK Healthcare's EV-to-Revenue or its related term are showing as below:

NSE:TTKHLTCARE' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.46   Med: 1.34   Max: 3.12
Current: 1.63

During the past 13 years, the highest EV-to-Revenue of TTK Healthcare was 3.12. The lowest was 0.46. And the median was 1.34.

NSE:TTKHLTCARE's EV-to-Revenue is ranked better than
65.3% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs NSE:TTKHLTCARE: 1.63

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), TTK Healthcare's stock price is ₹1476.95. TTK Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹528.74. Therefore, TTK Healthcare's PS Ratio for today is 2.79.


TTK Healthcare EV-to-Revenue Historical Data

The historical data trend for TTK Healthcare's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTK Healthcare EV-to-Revenue Chart

TTK Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 0.56 1.04 1.54 0.89

TTK Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.02 0.89 2.41 1.07 2.67

Competitive Comparison of TTK Healthcare's EV-to-Revenue

For the Drug Manufacturers - General subindustry, TTK Healthcare's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's EV-to-Revenue falls into.



TTK Healthcare EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

TTK Healthcare's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12171.285/7469.521
=1.63

TTK Healthcare's current Enterprise Value is ₹12,171 Mil.
TTK Healthcare's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7,470 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTK Healthcare  (NSE:TTKHLTCARE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

TTK Healthcare's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1476.95/528.741
=2.79

TTK Healthcare's share price for today is ₹1476.95.
TTK Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹528.74.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTK Healthcare EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of TTK Healthcare's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TTK Healthcare (NSE:TTKHLTCARE) Business Description

Traded in Other Exchanges
Address
No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.

TTK Healthcare (NSE:TTKHLTCARE) Headlines

No Headlines